TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 50 filers reported holding TALARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,704 | -42.4% | 10,571 | -37.7% | 0.00% | – |
| Q2 2023 | $51,549 | +4.0% | 16,957 | -35.7% | 0.00% | – |
| Q1 2023 | $49,551 | +137.5% | 26,357 | +28.9% | 0.00% | – |
| Q4 2022 | $20,861 | -55.6% | 20,452 | +13.7% | 0.00% | – |
| Q3 2022 | $47,000 | -11.3% | 17,981 | +53.8% | 0.00% | – |
| Q2 2022 | $53,000 | -51.8% | 11,689 | +4.9% | 0.00% | – |
| Q1 2022 | $110,000 | -73.6% | 11,139 | -59.2% | 0.00% | – |
| Q4 2021 | $417,000 | +47.3% | 27,304 | +31.0% | 0.00% | – |
| Q3 2021 | $283,000 | +379.7% | 20,847 | +414.2% | 0.00% | – |
| Q2 2021 | $59,000 | – | 4,054 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $5,513,299 | 6.67% |
| BML Capital Management, LLC | 1,929,484 | $3,627,430 | 3.14% |
| Western Standard LLC | 586,481 | $1,102,584 | 1.12% |
| Cormorant Asset Management, LP | 900,649 | $1,693 | 0.11% |
| Artal Group S.A. | 914,262 | $1,719 | 0.10% |
| Values First Advisors, Inc. | 52,896 | $99,445 | 0.06% |
| Blackstone Inc. | 8,089,315 | $15,207,912 | 0.06% |
| Eventide Asset Management | 1,561,092 | $2,934,853 | 0.05% |
| Marquette Asset Management, LLC | 101,375 | $190,585 | 0.05% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $6,184,480 | 0.03% |